The DHSS produced a public information leaflet for blood donors which stated that "Should just one of the donors be suffering from AIDS, then the Factor VIII could transmit the disease." Read more about The DHSS produced a public information leaflet for blood donors which stated that "Should just one of the donors be suffering from AIDS, then the Factor VIII could transmit the disease."
A memorandum from Dr Peter Foster to John Watt stated the assertion that the risk of contracting AIDS was one in one million. Read more about A memorandum from Dr Peter Foster to John Watt stated the assertion that the risk of contracting AIDS was one in one million.
Christopher Bishop described Professor Bloom as an influential figure and said he was later described by the pharmaceutical company's UK marketing manager as an "opinion former". Read more about Christopher Bishop described Professor Bloom as an influential figure and said he was later described by the pharmaceutical company's UK marketing manager as an "opinion former".
Professor Bloom assessed the size of the risk of AIDS by making reference to the number of AIDS cases developed in the UK and Europe amongst people with haemophilia. Read more about Professor Bloom assessed the size of the risk of AIDS by making reference to the number of AIDS cases developed in the UK and Europe amongst people with haemophilia.
Dr Biggs stated that "Cryoprecipitate is a simple concentrate made from plasma at all Regional Transfusion Centres. Cryoprecipitate is much superior to plasma for the treatment of haemophilia A patients but the material is very variable from one sample to another and the potency cannot be known before it is used. For each dose the assumption must be made that the material is of low potency thus there is a tendency to use more material for each patient than is probably needed." Read more about Dr Biggs stated that "Cryoprecipitate is a simple concentrate made from plasma at all Regional Transfusion Centres. Cryoprecipitate is much superior to plasma for the treatment of haemophilia A patients but the material is very variable from one sample to another and the potency cannot be known before it is used. For each dose the assumption must be made that the material is of low potency thus there is a tendency to use more material for each patient than is probably needed."
A hierarchy of safety used by the UKHCDO was implemented meaning that for those newly diagnosed with haemophilia, cryoprecipitate was used. Preference was then given to NHS Factor concentrate with US Factor concentrate given as a last resort. Read more about A hierarchy of safety used by the UKHCDO was implemented meaning that for those newly diagnosed with haemophilia, cryoprecipitate was used. Preference was then given to NHS Factor concentrate with US Factor concentrate given as a last resort.
At a meeting of the CSM(B), it was stated that clotting concentrates were "life-saving" for haemophiliacs and the risk of AIDs was considered small. It was concluded that withdrawal of clotting factor concentrates from the market was not feasible on the grounds of supply. Read more about At a meeting of the CSM(B), it was stated that clotting concentrates were "life-saving" for haemophiliacs and the risk of AIDs was considered small. It was concluded that withdrawal of clotting factor concentrates from the market was not feasible on the grounds of supply.
At a meeting of the Reference Centre Directors it was agreed that for young children, and those who were newly diagnosed with haemophilia, cryoprecipitate was to be used. Next preference was to be given to NHS factor concentrate. Read more about At a meeting of the Reference Centre Directors it was agreed that for young children, and those who were newly diagnosed with haemophilia, cryoprecipitate was to be used. Next preference was to be given to NHS factor concentrate.
In a minute from Dr Smith to Dr Lane, it was suggested that importation of US concentrate should cease on the ground of the risk of hepatitis alone. Read more about In a minute from Dr Smith to Dr Lane, it was suggested that importation of US concentrate should cease on the ground of the risk of hepatitis alone.
Professor Tedder emphasized in his oral evidence that the use of prisoners for donated blood, particularly in the US, meant that the producer of the product would not know their donor. Read more about Professor Tedder emphasized in his oral evidence that the use of prisoners for donated blood, particularly in the US, meant that the producer of the product would not know their donor.